Fall Clinical Dermatology Conference

For many years, genetic expression profiling has helped physicians predict which patients are at the highest risk of having their melanoma metastasize. Now, this same approach could aid in treating squamous cell carcinoma of the skin.

Hilary Baldwin, M.D., discusses the nuances of adult female acne and its treatments in her presentation at the Fall Clinical Dermatology Conference in Las Vegas.

Researcher experiments with reformulating psoriasis topical as a lotion instead of cream, which performed well with patients.

Cosmetic products with prebiotics, probiotics and postbiotics may be beneficial in treating eczema, a physician reported at the Fall Clinical Dermatology Conference held earlier this month in Las Vegas.

Patients are increasingly seeking to have benign lesions removed and today, there are a number of treatment options available to safely and effectively remove unwanted lesions. Suneel Chilukuri, M.D., reviewed these options during a presentation at the Fall Clinical Dermatology Conference held this week in Las Vegas.

Qbrexza was approved earlier this year for primary axillary hyperhidrosis. And, now, other treatments are under study. In his presentation at this week’s Fall Clinical Dermatology Conference in Las Vegas, Dr. David Pariser summarizes the latest research.

In a presentation at the Fall Clinical Dermatology Conference held on Saturday in Las Vegas, Diane Berson, M.D., outlined trends and new ingredients in oral and topical cosmeceuticals.

Photodynamic therapy (PDT) has multiple uses, but billing can be complicated. In this article, we outline its uses and billing codes.

At the Fall Clinical Dermatology Conference in Las Vegas, one practical talk with a lot of takeaways was a workshop on two types of diagnostic tests for mole genomics.

While botulinum toxin is most commonly used to relieve frowns and wrinkles, it is increasingly being shown to be associated with improving mood and relationships, a researcher says.

There are plenty of laser technologies for the practice, but then there are cornerstone lasers every practice should have. Learn more in this article from the Fall Clinical conference.

Two approved and two pending anti-IL 23 drugs offer an opportunity for moderate to severe psoriasis patients to regain their lives, according to researchers presenting at the 2018 Fall Clinical Dermatology Conference.

Reporting from Fall Clinical in Las Vegas, Dr. James Del Rosso reviews best practices for topical therapy uses in psoriasis and atopic dermatitis.